Clinical Trial Update: A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer [Phase 2]

View source ↗

Summary

A multicenter Phase II study evaluating neoadjuvant docetaxel, cisplatin, and capecitabine with protocolized surgery for resectable gastric cancer has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Jeroen Bosch Ziekenhuis | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED